EU should update its research policy on stem cells
Human embryonic stem cell research is no longer patentable in the EU, it is ethically problematic and therefore is not a consensual research field among Member States and EU citizens. Moreover, it offers less and less clinical promise. COMECE therefore calls on the EU to exclude human embryonic stem cell research from its upcoming research funding programme Horizon 2020 and to focus instead on the more innovative and promising field of alternative stem cell research.